Area of research
Cancer Research · Pulmonary and Respiratory Medicine
Research interest
Research focused on Cancer research and Cancer, with related work in Vimentin, MFN2, Muscarinic acetylcholine receptor. Notable publications include 'MicroRNA-7 Inhibits Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer Cells via Targeting FAK Expression', 'Inhibition of miR-23a attenuates doxorubicin-induced mitochondria-dependent cardiomyocyte apoptosis by targeting the PGC-1α/Drp1 pathway', and 'Choline Attenuates Cardiac Fibrosis by Inhibiting p38MAPK Signaling Possibly by Acting on M3 Muscarinic Acetylcholine Receptor'.
Plasma-only circulating tumor DNA analysis detects minimal residual disease and predicts early relapse in hepatocellular carcinoma patients undergoing curative resection
Up-regulated SPP1 increases the risk from IPF to lung cancer via activating the pro-tumor macrophages
Multi-omics integration analysis unveils heterogeneity in breast cancer at the individual level
Systematic exploration of the underlying mechanism of gemcitabine resistance in pancreatic adenocarcinoma
Systematic analyses identify the anti-fibrotic role of lncRNA TP53TG1 in IPF
Upregulation of CXCL1 and LY9 contributes to BRCAness in ovarian cancer and mediates response to PARPi and immune checkpoint blockade
A genetic map of the chromatin regulators to drug response in cancer cells
FDRdb: a manually curated database of fibrotic disease–associated RNAome and high-throughput datasets
Individualized lncRNA differential expression profile reveals heterogeneity of breast cancer
A transcriptional signature detects homologous recombination deficiency in pancreatic cancer at the individual level
LncRNA CTD-2528L19.6 prevents the progression of IPF by alleviating fibroblast activation
Discovering a qualitative transcriptional signature of homologous recombination defectiveness for prostate cancer
Revealing biomarkers associated with PARP inhibitors based on genetic interactions in cancer genome
Pan‐cancer multi‐omics analyses reveal crosstalk between the Hippo and immune signaling pathways in the tumor microenvironment
An individualized transcriptional signature to predict the epithelial-mesenchymal transition based on relative expression ordering
Aloe-emodin relieves zidovudine-induced injury in neonatal rat ventricular myocytes by regulating the p90rsk/p-bad/bcl-2 signaling pathway
Inhibition of miR-23a attenuates doxorubicin-induced mitochondria-dependent cardiomyocyte apoptosis by targeting the PGC-1α/Drp1 pathway
Choline Attenuates Cardiac Fibrosis by Inhibiting p38MAPK Signaling Possibly by Acting on M3 Muscarinic Acetylcholine Receptor
Aurora-A/ERK1/2/mTOR axis promotes tumor progression in triple-negative breast cancer and dual-targeting Aurora-A/mTOR shows synthetic lethality
Genetic Interaction-Based Biomarkers Identification for Drug Resistance and Sensitivity in Cancer Cells
RHPCG: a database of the Regulation of the Hippo Pathway in Cancer Genome
A landscape of synthetic viable interactions in cancer
MicroRNA-7 Inhibits Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer Cells via Targeting FAK Expression